Jacobson Pharma Updates on TAILORx Study
- Written by Reporters
Landmark TAILORx[1] Results, Published in The New England Journal of Medicine, Demonstrate the Oncotype DX Breast Recurrence Score® Test Definitively Identifies the 70% of Women with Early-stage Breast Cancer Who Receive No Benefit from Chemotherapy, and the 30% of Women for Whom Chemotherapy Benefit Can...